Similar articles for PMID: 35589407

Year	Number of Results
2004	1
2009	1
2011	3
2012	4
2013	6
2014	5
2015	5
2016	7
2017	13
2018	13
2019	16
2020	15
2021	20
2022	18
2023	4

1

First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using ¹⁸F-labeled Active-Site Inhibited Factor VII (¹⁸F-ASIS): Potential as Companion Diagnostic.

Loft M, Christensen C, Clausen MM, Carlsen EA, Hansen CP, Kroman N, Langer SW, Høgdall C, Madsen J, Gillings N, Nielsen CH, Klausen TL, Holm S, Loft A, Berthelsen AK, Kjaer A. Loft M, et al. J Nucl Med. 2022 Dec;63(12):1871-1879. doi: 10.2967/jnumed.122.264068. Epub 2022 May 19. J Nucl Med. 2022. PMID: 35589407 Clinical Trial.

2

Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Erlandsson M, Jeppesen TE, Jensen MM, Kristensen LK, Madsen J, Petersen LC, Kjaer A. Nielsen CH, et al. J Nucl Med. 2016 Jan;57(1):89-95. doi: 10.2967/jnumed.115.154849. Epub 2015 Sep 17. J Nucl Med. 2016. PMID: 26383146 Free article.

3

PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Jeppesen TE, Kristensen LK, Jensen MM, El Ali HH, Madsen J, Wiinberg B, Petersen LC, Kjaer A. Nielsen CH, et al. J Nucl Med. 2016 Jul;57(7):1112-9. doi: 10.2967/jnumed.115.170266. Epub 2016 Mar 24. J Nucl Med. 2016. PMID: 27013699 Free article.

4

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

5

Synthesis and characterization of (18)F-labeled active site inhibited factor VII (ASIS).

Erlandsson M, Nielsen CH, Jeppesen TE, Kristensen JB, Petersen LC, Madsen J, Kjaer A. Erlandsson M, et al. J Labelled Comp Radiopharm. 2015 May 15;58(5):196-201. doi: 10.1002/jlcr.3282. Epub 2015 Mar 27. J Labelled Comp Radiopharm. 2015. PMID: 25820758

6

High in-vivo stability in preclinical and first-in-human experiments with [¹⁸F]AlF-RESCA-MIRC213: a ¹⁸F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers.

Qin X, Guo X, Liu T, Li L, Zhou N, Ma X, Meng X, Liu J, Zhu H, Jia B, Yang Z. Qin X, et al. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):302-313. doi: 10.1007/s00259-022-05967-7. Epub 2022 Sep 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36129493

7

Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.

Tian M, Ogawa K, Wendt R, Mukhopadhyay U, Balatoni J, Fukumitsu N, Uthamanthil R, Borne A, Brammer D, Jackson J, Mawlawi O, Yang B, Alauddin MM, Gelovani JG. Tian M, et al. J Nucl Med. 2011 Jun;52(6):934-41. doi: 10.2967/jnumed.110.086777. Epub 2011 May 13. J Nucl Med. 2011. PMID: 21571803 Free PMC article.

8

¹⁸F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients.

O'Doherty J, Jauregui-Osoro M, Brothwood T, Szyszko T, Marsden PK, O'Doherty MJ, Cook GJR, Blower PJ, Lewington V. O'Doherty J, et al. J Nucl Med. 2017 Oct;58(10):1666-1671. doi: 10.2967/jnumed.117.192252. Epub 2017 Apr 6. J Nucl Med. 2017. PMID: 28385795 Free PMC article.

9

First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.

Krebs S, Veach DR, Carter LM, Grkovski M, Fornier M, Mauro MJ, Voss MH, Danila DC, Burnazi E, Null M, Staton K, Pressl C, Beattie BJ, Zanzonico P, Weber WA, Lyashchenko SK, Lewis JS, Larson SM, Dunphy MPS. Krebs S, et al. J Nucl Med. 2020 Nov;61(11):1580-1587. doi: 10.2967/jnumed.119.234864. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169913 Free PMC article.

10

Biodistribution and Dosimetry of ¹⁸F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.

Pandit-Taskar N, Zanzonico P, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko S, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S. Pandit-Taskar N, et al. J Nucl Med. 2018 Jan;59(1):147-153. doi: 10.2967/jnumed.117.193169. Epub 2017 Jul 13. J Nucl Med. 2018. PMID: 28705916 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed